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1. Introduction 
Ox pituitary growth hormone possesses two N-ter- 
minal residues (phenylalanine and alanine) [I], and 
therefore two types of polypeptide chain. The mole- 
cular weight of the hormone has been found in recent 
studies to be 20-26,000 [2-71, and if a value in this 
range is accepted there are about 0.5 moles of each 
N-terminal residue/mole of protein. The presence of a 
total of only one mole of N-terminal acids/mole of 
protein suggests that there cannot be a covalent link 
between the polypeptide chains (cf. the branched 
chain model proposed in [8]), and such a conclusion 
is supported by studies on the amino acid sequence of 
ox growth hormone [6,9, IO] , which suggest un- 
branched chains, each containing about 200 amino 
acid residues. However, attempts to separate the alanyl 
and phenylalanyl chains have been unsuccessful. In 
this paper studies on the N-terminal sequences of ox 
growth hormone are described, which indicate that, 
near the N-terminus anyway, the two chains differ 
only by the presence or absence of a single alanine 
residue. 
The N-terminal sequences were investigated in two 
ways: 
(1) determination of the N-terminal sequence using 
the “dansyl”-Edman technique. 
(2) investigation of peptides derived from the N- 
terminus by cleavage after methionine residues with 
cyanogen bromide. 
2. Experimental 
Ox growth hormone was prepared by a chromato- 
graphic method [7]. It contained about 0.4 @moles of 
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alanine and 0.4 moles of phenylalanine as N-terminal 
amino acids in 20 mg of protein (i.e. in 1 pmole of 
protein if the molecular weight is 20,000). 
Stepwise degradation of growth hormone was based 
on the “dansyl”-Edman technique of Gray [I l] . 2 mg 
of growth hormone and 20 fi of phenylisothiocyanate 
were reacted in 0.2 ml of buffer “M” (containing 60 
ml N-ethyl morpholine, 1.5 ml acetic acid, 500 ml 
ethanol and 438 ml water; by volume [ 121) at 37” for 
2% h and then dried in an evacuated desiccator and 
extracted with 2 X 1 ml benzene. The dried residue 
was dissolved in 0.5 ml trifluoroacetic acid, stood at 
20” for 1 h and an aliquot equivalent to 0.2 mg of 
growth hormone was then removed for N-terminal 
analysis by the “dansyl”-method [ 131. The remainder 
of the peptide was dried and put through another 
cycle of the degradative procedure to determine the 
next residue. The procedure was repeated for 5-6 
cycles, after which the results became difficult to inter- 
pret. 
The aliquot taken for “dansylation” was reacted 
with 40 /.d 0.1 M NaHCO, and 40 /_d “dansyl” 
chloride (2.5 mg/ml in acetone) for 3 h at 20”. 
“Dansyl”-protein was hydrolysed with 0.1 ml 6 N HCl 
(sealed tube, 1 IO”) for 4 or 16 h (the shorter hydro- 
lysis time gives better recoveries of some “dansyl”- 
amino acids, especially “dansyl”-proline [ 131). 
“Dansyl”-amino acids were separated and identified 
by high voltage paper electrophoresis [ 131 or by 
chromatography on polyamide sheets [ 141. 
For cleavage of growth hormone with cyanogen 
bromide, 100 mg of protein, 50 mg of cyanogen 
bromide and 10 ml of 75% formic acid were incubated 
at 20” for 16 h. The mixture was dried to about 1 ml 
on a rotary evaporator, diluted to 15-20 ml with 
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water, and then freeze dried. Determination of the 
N-terminal residues of the material so treated indi- 
cated that lysine, arginine, and :-rine had been ex- 
posed in addition to the phenylalanine and alanine 
originally present. The reaction products were sepa- 
rated into soluble and insoluble fractions by extrac- 
tion with pH 6.5 buffer (1% pyridine, 0.3% acetic 
acid, 89.7% water; by volume). Most of the N-terminal 
phenylahurine and alanine now proved to have passed 
into the soluble fraction, which was therefore exa- 
mined further to obtain peptides derived from the N- 
terminus. 
The soluble fraction was submitted to gel fdtration 
on Sephadex G-15 in 50% acetic acid, and the retarded 
peptides (which had N-terminal alanine and phenyl- 
alanine) were further fractionated by high voltage paper 
electrophoresis (pH 2; 2% formic acid, 8% acetic acid, 
9% water; by volume) and recovered by elution with 
the same buffer (after staining a guide strip for detec- 
tion). 
Amino acid analyses were performed with a Beck- 
man amino acid analyser, Model 120C. N-terminal 
groups and sequences of peptides were determined by 
the “dansyl” and “dansyl’‘-Edman methods [ 11,131. 
3. Results and Discussion 
3.1. “Dansyl’-Edman degradation 
The “dansyl’‘-Edman degradation of ox growth 
hormone is complicated by the fact that two chains 
are being degraded at once. The new N-terminal amino 
acids exposed after each cycle of the Edman reaction 
Table 1 
Edman degradation of ox growth hormone. 
Number of Edman steps Residues detected 
0 Phe, Ala 
1 Pro, Phe 
2 Ala, Pro 
3 Met, Ala 
4 Ser, Met 
5 Leu, Ser 
are indicated in table 1. These results could arise from 
the degradation of two very similar chains, one of 
which had an extra residue at the N-terminal end. The 
proposed sequences are shown in fig. 1, where they 
are compared with the N-terminal sequence of human 
growth hormone [ 151. Ox and human growth hor- 
mones are clearly homologous in this region, though 
the human hormone has only a single type of chain, 
beginning with phenylalanine. 
3.2. Cyanogen bromide cleavage 
The results of the Edman degradation suggest hat 
there is a methionine residue near the N-terminus of 
the molecule, which should be susceptible to cleavage 
by cyanogen bromide. When the products of cyanogen 
bromide cleaved growth hormone were examined, two 
small peptides were obtained (by electrophoresis of 
the fraction retarded on Sephadex G-l 5) one with N- 
terminal alanine (CN-la), the second with N-terminal 
phenylalanine (CN-lb). These had the following amino 
acid compositions: 
CN-la: Pro (1 .O), Ala (1.9), Phe (1 .O), Homoserine 
+ Homoserine lactone (0.7) [and a trace of Ser (0. l)] . 
CN-lb: Pro (1.0) Ala (l.O), Phe (l.O), Homoserine 
+ Homoserine lactone (0.8). 
The sequences of these two peptides were deter- 
mined by “dansyl”-Edman degradation: 
CN-la: Ala-Phe-Pro-Ala-Homoserine lactone 
CN-lb: - - - Phe-ProAla-Homoserine lactone --- 
CN-la and CN-lb can clearly derive from the two 
N-terminal sequences proposed above (fig. 1) by 
cleavage after methionine (residue 5 of the alanyl 
chain, residue 4 of the phenylalanyl chain) and conver- 
sion of methionine to homoserine or its lactone. The 
results from cyanogen bromide cleavage thus con- 
firm the idea that the two chains of ox growth hor- 
mone are very similar near the N-terminus, differing 
only by the presence or absence of a single alanine 
residue. Studies on the primary structure of the re- 
mainder of the ox growth hormone molecule [6,9,10] 
suggest hat the rest of the chains may also be very 
similar, and possibly, identical. 
Fellows [ 161 has also investigated the products of 
cyanogen bromide cleavage of ox growth hormone, 
but reported only the presence of a peptide equivalent 
to CN-lb, which by itself cannot explain the two N- 
terminal residues of the parent hormone. Parcells and 
Li [ 171 studied peptides obtained from dinitrophenyl- 
119 
Volume 3, number 2 April 1969 FEBSLETTERS 
Phenylalanyl chain : HaN-Phe-Pro-Ala-Met-Ser-Leu . . . . . 
Ox growth hormone 
Alanyl chain : HaN-Ala-Phe-Pro-Ala-Met-Ser-Leu . . _ . 
Human growth hormone : HzN-PheProThr-Be-Pro-Leu , . . . . 
Fig. 1. N-terminal sequences proposed for the two chains of ox growth hormone. The N-terminal sequence of human growth 
hormone [ 151 is included for comparison. 
ated growth hormone, and obtained two N-terminal 
sequences which do not agree well with the sequences 
given here. 
3.3. Origin of the two growth hormone chains 
It is not yet clear how the two chains of ox growth 
hormone arise. Removal of the N-terminal alanine by 
an enzyme during isolation is a possible explanation, 
but if this is the case the fact that the two chains occur 
in nearly equal proportions after several quite different 
purification procedures is surprising. Possibly enzymic 
degradation occurs in the gland before isolation, per- 
haps during activation of a growth hormone precur- 
sor. Alternatively the difference could have a genetic 
origin, due either to the presence of two alleles with- 
in the population of animals from which the glands 
are obtained, or to duplication of the gene which codes 
for growth hormone. 
There is strong evidence that under many condi- 
tions ox growth hormone tends to aggregate, and that 
the predominant form of the hormones in some cir- 
cumstances is a dimer. This explains earlier molecular 
weight determinations, which gave a value of about 
45,000 [8,18]. Whether the alanyl and phenylalanyl 
chains are distributed in a random fashion among such 
dimers, or whether specific dimers (containing either 
dissimilar chains or similar chains) are favoured, is not 
yet clear. 
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